Key result
Dietary chitosan lowers total cholesterol but high doses increase postprandial triglycerides.
Why the study?
The effects of long-term chitosan feeding on postprandial lipid response and lipid metabolism in a high-sucrose-diet-impaired glucose-tolerant model were not well understood.
Does chitosan supplementation improve lipid metabolism in a high-sucrose-diet-impaired glucose-tolerant rat model?
Does chitosan supplementation improve lipid metabolism in a high-sucrose-diet-impaired glucose-tolerant rat model?
Chitosan supplementation improves lipid metabolism in a high-sucrose-diet rat model, though high doses may increase postprandial triglycerides via an ANGPTL4-regulated pathway.
Does not support human use of chitosan for lipids; leaves open dose-specific effects for further animal and translational research.
This study was designed to investigate the effects of long-term feeding of chitosan on postprandial lipid response and lipid metabolism in a high-sucrose (HS)-diet-impaired glucose-tolerant rat model. As the results, HS-diet-fed rats supplemented with 5 and 7% chitosan in diets for 9 weeks had lower postprandial plasma total cholesterol (TC) levels, but 7% chitosan in the diet had higher postprandial plasma triglyceride (TG) and TG-rich lipoprotein TG levels. Supplementation of chitosan significantly decreased the postprandial ratio of apolipoprotein B (apoB)48/apoB100 in TG-rich lipoprotein fractions of HS-diet-fed rats. Long-term supplementation of 5 and 7% chitosan in diets for 16 weeks had lower plasma TC, low-density lipoprotein cholesterol (LDL-C) + very low density lipoprotein cholesterol (VLDL-C), TC/high-density lipoprotein (HDL-C) ratio, leptin, and tumor necrosis factor-α (TNF-α) levels in HS-diet-fed rats. Moreover, it was noticed that the VLDL receptor (VLDLR) protein expression in skeletal muscles of HS-diet-fed rats was significantly decreased, which could be significantly reversed by supplementation of 5 and 7% chitosan. Rats supplemented with 7% chitosan in the diet significantly elevated the lipolysis rate and decreased the accumulation of TG in epididymal fat pads of HS-diet-fed rats. The plasma angiopoietin-like 4 (ANGPTL4) protein expression was not affected in HS-diet-fed rats, but it was significantly increased in 7% chitosan-supplemented HS-diet-fed rats. Taken together, these results indicate that supplementation of chitosan in the diet can improve the impairment of lipid metabolism in a HS-diet-fed rat model, but long-term high-dose chitosan feeding may enhance postprandial plasma TG and TG-rich lipoprotein TG levels in HS-diet-fed rats through an ANGPTL4-regulated pathway.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2012) studied High-sucrose-diet-impaired glucose-tolerant rat model. Chitosan vs. High-sucrose diet without chitosan was evaluated on Postprandial lipid response and lipid metabolism. Long-term supplementation of 5% and 7% chitosan in diets improved lipid metabolism by lowering plasma total cholesterol, but 7% chitosan increased postprandial plasma triglycerides.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: